This FAQ series, available in French, was developed by Breakthrough ACTION Mali in collaboration with the National Communication Sub-Commission of the COVID-19 Crisis Committee. The series was distributed across a range of partners as part of the COVID-19 vaccination campaign in 2021. Content was developed in collaboration with all partners and adapts key information and messages of the World Health Organization’s COVID Vaccine FAQs and detailed SAGE recommendations to the context of Mali’s vaccine campaign, its vaccine eligible populations and available vaccine types.
The series includes:
- COVID-19 vaccine FAQ for Health workers
- FAQ for the general public
- AstraZeneca vaccine FAQ
- Johnson & Johnson/Janssen vaccine FAQ